Outcomes and Adverse Events Among Patients with Vancomycin-Resistant Enterococcal Bloodstream Infection Treated with Daptomycin Doses Greater than 12 mg/kg

Abstract Introduction Daptomycin is commonly used for vancomycin-resistant enterococcal bloodstream infections (VRE-BSIs); however, its optimal dosing remains uncertain. Although doses > 12 mg/kg may improve attainment of pharmacodynamic targets, clinical outcomes and safety data for very-high–dose...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Luo-Wei Lin, Yu-Chung Chuang, Jia-Ling Yang, Chi-Ying Lin, Sung-Hsi Huang, Jann-Tay Wang, Yee-Chun Chen, Shan-Chwen Chang
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Adis, Springer Healthcare 2026-05-01
Colecção:	Infectious Diseases and Therapy
Assuntos:	Daptomycin Vancomycin-resistant enterococcus Bloodstream infection Creatine kinase Eosinophilic pneumonia
Acesso em linha:	https://doi.org/10.1007/s40121-026-01369-6
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!